- $985.42m
- $2.45bn
- $1.38bn
- 27
- 85
- 84
- 71
R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,365 | 2,900 | 1,870 | 1,460 | 1,379 |
Cost of Revenue | |||||
Gross Profit | 440 | 593 | 393 | 387 | 388 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,640 | 2,842 | 2,196 | 1,367 | 1,174 |
Operating Profit | -275 | 57.9 | -326 | 92.7 | 205 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -333 | -23.6 | -448 | -37.8 | 95.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -327 | -29.4 | -451 | -42.8 | 89.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -327 | -29.4 | -451 | -42.8 | 89.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -327 | -29.4 | -451 | -42.8 | 89.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.1 | 1.21 | -3.49 | -0.234 | 0.42 |
Dividends per Share |